DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced the appointment of David M. Weber, Ph.D., as Chief Operating Officer effective immediately. Dr. Weber will be responsible for Abiomed’s global operations initiatives and will play a key role in developing strategic plans relative to Abiomed’s product portfolio of advanced circulatory support technologies.
